Spots Global Cancer Trial Database for herpes simplex virus type 1
Every month we try and update this database with for herpes simplex virus type 1 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors | NCT05860374 | Sarcoma Carcinoma Breast Cancer Pancreatic Canc... Colorectal Canc... Gastric Cancer Liver Cancer Lung Cancer Gynecologic Can... | Recombinant onc... | 18 Years - 75 Years | Shanghai Yunying Medical Technology | |
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer | NCT05830240 | Head and Neck C... Esophageal Canc... Otorhinolaryngo... Ear Cancer Nose Cancer Laryngeal Cance... Pharyngeal Canc... | Recombinant onc... | 18 Years - 75 Years | Shanghai Yunying Medical Technology | |
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors | NCT06171282 | Osteosarcoma Sarcoma Soft Tissue Sar... Bone Tumor | Recombinant onc... | 16 Years - 75 Years | Shanghai Yunying Medical Technology | |
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors | NCT05961111 | Sarcoma Carcinoma Digestive Cance... Breast Cancer Lung Cancer Brain Cancer Melanoma Gynecologic Can... Head and Neck C... Kidney Cancer | Recombinant onc... | 18 Years - 75 Years | Shanghai Yunying Medical Technology | |
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Bone and Soft Tissue Tumors | NCT05851456 | Osteosarcoma Sarcoma Sarcoma,Soft Ti... Bone Tumor | Recombinant onc... | 14 Years - 75 Years | Shanghai Yunying Medical Technology | |
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors | NCT05886075 | Lung Cancer Bronchial Cance... Non Small Cell ... Small Cell Lung... Sarcoma Colorectal Canc... Gastric Cancer Liver Cancer Breast Cancer Pancreatic Canc... Head and Neck C... Ovarian Cancer | Recombinant onc... | 18 Years - 75 Years | Shanghai Yunying Medical Technology | |
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors | NCT05886075 | Lung Cancer Bronchial Cance... Non Small Cell ... Small Cell Lung... Sarcoma Colorectal Canc... Gastric Cancer Liver Cancer Breast Cancer Pancreatic Canc... Head and Neck C... Ovarian Cancer | Recombinant onc... | 18 Years - 75 Years | Shanghai Yunying Medical Technology | |
A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Relapsed/Refractory Head and Neck Cancer | NCT05830240 | Head and Neck C... Esophageal Canc... Otorhinolaryngo... Ear Cancer Nose Cancer Laryngeal Cance... Pharyngeal Canc... | Recombinant onc... | 18 Years - 75 Years | Shanghai Yunying Medical Technology |